The role of non‐oropharyngeal biopsies in head and neck squamous cell carcinoma of unknown primary: A systematic review
Open Access
- 25 April 2024
- journal article
- review article
- Published by Wiley in Clinical Otolaryngology
- Vol. 49 (5) , 531-537
Abstract
Introduction: This systematic review aims to evaluate the role of biopsies in non‐oropharyngeal subsites in patients with cervical metastasis from head and neck squamous cell carcinoma of unknown primary (HNSCCUP).Methods: This systematic review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) statement. Articles that encompassed non‐oropharyngeal biopsies in HNSCCUP as part of the diagnostic work‐up were selected and analysed.Results: A comprehensive search strategy was used to search relevant literature in PubMed from inception to October 2021. Eleven articles out of 860 were included, comprising 990 patients. There are no randomised control trials comparing the outcomes of survival and or locoregional control between patients who have or have not undergone non‐targeted biopsies of non‐oropharyngeal sub‐sites for HNSCCUP.Several retrospective studies which showed an extremely low yield from random biopsies (range of yield, 0%–9%) of non‐oropharyngeal subsites. Even targeted biopsies showed a low yield (range of yield, 0.6%–16.6%) from non‐oropharyngeal subsites. The primary site identified for Epstein–Barr virus (EBV) positive cervical lymph nodes with an unknown primary is mainly the nasopharynx (51.7%). Narrow band imaging (NBI) (sensitivity range, 64%–91%) helps in the detection of primaries to target biopsies in non‐oropharyngeal subsites.Conclusions: On the basis of this systematic review, it is not appropriate to offer biopsies of clinically and radiologically normal upper aerodigestive tract mucosa at non‐oropharyngeal sites. Offer nasopharyngeal biopsies when the cervical node sampling reveals EBV‐positive metastasis. Where available, NBI should be used to help detect and target biopsies in non‐oropharyngeal subsites.Keywords
This publication has 25 references indexed in Scilit:
- Narrow band imaging in head and neck unknown primary carcinoma: A systematic review and meta‐analysisThe Laryngoscope, 2019
- The Impact of a Stepwise Approach to Primary Tumor Detection in Squamous Cell Carcinoma of the Neck With Unknown PrimaryThe Laryngoscope, 2018
- Role of narrow‐band imaging in detection of head and neck unknown primary squamous cell carcinomaThe Laryngoscope, 2018
- Challenging the need for random directed biopsies of the nasopharynx, pyriform sinus, and contralateral tonsil in the workup of unknown primary squamous cell carcinoma of the head and neckHead & Neck, 2014
- Role of 18F-FDG PET in detecting primary site in the patient with primary unknown carcinoma2010
- Prospective study of 18FDG‐PET in the detection and management of patients with lymph node metastases to the neck from an unknown primary tumor. Results from the DAHANCA‐13 studyHead & Neck, 2007
- Management of the unknown primary carcinoma: Long‐term follow‐up on a negative PET scan and negative panendoscopyHead & Neck, 2007
- Diagnosis and management of carcinoma of unknown primary in the head and neckEuropean Archives of Oto-Rhino-Laryngology, 2003
- Diagnostic strategies in cervical carcinoma of an unknown primary (CUP)European Archives of Oto-Rhino-Laryngology, 2002
- Cervical metastasis from the unknown primary tumor1995